{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T11:25:01Z","timestamp":1781090701442,"version":"3.54.1"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T00:00:00Z","timestamp":1637107200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T00:00:00Z","timestamp":1637107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071006"],"award-info":[{"award-number":["82071006"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of\u00a0Hunan Province","doi-asserted-by":"publisher","award":["2020JJ4129"],"award-info":[{"award-number":["2020JJ4129"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Independent Exploration and Innovation Project of Graduate Students in Central South University","award":["2021zzts1086"],"award-info":[{"award-number":["2021zzts1086"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s00417-021-05456-x","type":"journal-article","created":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T06:03:41Z","timestamp":1637129021000},"page":"1043-1054","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["The risk factors for Graves\u2019 ophthalmopathy"],"prefix":"10.1007","volume":"260","author":[{"given":"Jiamin","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhe","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuokun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3017-9895","authenticated-orcid":false,"given":"Wei","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,17]]},"reference":[{"issue":"1","key":"5456_CR1","doi-asserted-by":"publisher","first-page":"T29","DOI":"10.1530\/JME-17-0276","volume":"61","author":"M Mohyi","year":"2018","unstructured":"Mohyi M, Smith TJ (2018) 40 YEARS OF IGF1: IGF1 receptor and thyroid-associated ophthalmopathy. J Mol Endocrinol 61(1):T29\u2013T43. https:\/\/doi.org\/10.1530\/JME-17-0276","journal-title":"J Mol Endocrinol"},{"issue":"8","key":"5456_CR2","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1056\/NEJMra0905750","volume":"362","author":"RS Bahn","year":"2010","unstructured":"Bahn RS (2010) Graves\u2019 Ophthalmopathy New Engl J Med 362(8):726\u2013738. https:\/\/doi.org\/10.1056\/NEJMra0905750","journal-title":"Graves' Ophthalmopathy New Engl J Med"},{"issue":"4","key":"5456_CR3","doi-asserted-by":"publisher","first-page":"G43","DOI":"10.1530\/EJE-21-0479","volume":"185","author":"L Bartalena","year":"2021","unstructured":"Bartalena L, Kahaly GJ, Baldeschi L, Dayan CM, Eckstein A, Marcocci C, Marino M, Vaidya B, Wiersinga WM (2021) The 2021 European Group on Graves\u2019 orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves\u2019 orbitopathy. Eur J Endocrinol 185(4):G43\u2013G67. https:\/\/doi.org\/10.1530\/EJE-21-0479","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"5456_CR4","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/jcpe.12650","volume":"44","author":"P Bouchard","year":"2017","unstructured":"Bouchard P, Carra MC, Boillot A, Mora F, Range H (2017) Risk factors in periodontology: a conceptual framework. J Clin Periodontol 44(2):125\u2013131. https:\/\/doi.org\/10.1111\/jcpe.12650","journal-title":"J Clin Periodontol"},{"issue":"4","key":"5456_CR5","doi-asserted-by":"publisher","first-page":"639","DOI":"10.2174\/1381612823666170111095723","volume":"23","author":"A Grzybowski","year":"2017","unstructured":"Grzybowski A, Nita M (2017) Smoking and eye pathologies. A systemic review. Part II. Retina Diseases, Uveitis Optic Neuropathies, Thyroid-Associated Orbitopathy. Curr Pharm Design 23(4):639\u2013654. https:\/\/doi.org\/10.2174\/1381612823666170111095723","journal-title":"Curr Pharm Design"},{"issue":"2","key":"5456_CR6","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41433-018-0242-9","volume":"33","author":"JCP Roos","year":"2019","unstructured":"Roos JCP, Paulpandian V, Murthy R (2019) Serial TSH-receptor antibody levels to guide the management of thyroid eye disease: the impact of smoking, immunosuppression, radio-iodine, and thyroidectomy. Eye 33(2):212\u2013217. https:\/\/doi.org\/10.1038\/s41433-018-0242-9","journal-title":"Eye"},{"key":"5456_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/4676289","volume":"2016","author":"H Kau","year":"2016","unstructured":"Kau H, Wu S, Tsai C, Liu CJ, Wei Y (2016) Cigarette Smoke Extract-Induced Oxidative Stress and Fibrosis-Related Genes Expression in Orbital Fibroblasts from Patients with Graves\u2019 Ophthalmopathy. Oxid Med Cell Longev 2016:1\u201310. https:\/\/doi.org\/10.1155\/2016\/4676289","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"5456_CR8","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1159\/000348246","volume":"2","author":"WM Wiersinga","year":"2013","unstructured":"Wiersinga WM, Regensburg NI, Mourits MP (2013) Differential involvement of orbital fat and extraocular muscles in graves\u2019 ophthalmopathy. Eur Thyroid J 2(1):14\u201321. https:\/\/doi.org\/10.1159\/000348246","journal-title":"Eur Thyroid J"},{"issue":"3","key":"5456_CR9","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3980\/j.issn.2222-3959.2014.03.03","volume":"7","author":"CL Chng","year":"2014","unstructured":"Chng CL, Lai OF, Chew CS, Peh YP, Fook-Chong SM, Seah LL, Khoo DH (2014) Hypoxia increases adipogenesis and affects adipocytokine production in orbital fibroblasts-a possible explanation of the link between smoking and Graves\u2019 ophthalmopathy. Int J Ophthalmol-Chi 7(3):403\u2013407. https:\/\/doi.org\/10.3980\/j.issn.2222-3959.2014.03.03","journal-title":"Int J Ophthalmol-Chi"},{"issue":"12","key":"5456_CR10","doi-asserted-by":"publisher","first-page":"4834","DOI":"10.1210\/jc.2016-1279","volume":"101","author":"G G\u00f6rtz","year":"2016","unstructured":"G\u00f6rtz G, Horstmann M, Aniol B, Reyes BD, Fandrey J, Eckstein A, Berchner-Pfannschmidt U (2016) Hypoxia-Dependent HIF-1 Activation Impacts on Tissue Remodeling in Graves\u2019 Ophthalmopathy\u2014Implications for Smoking. J Clin Endocrinol Metab 101(12):4834\u20134842. https:\/\/doi.org\/10.1210\/jc.2016-1279","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"5456_CR11","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1089\/thy.2014.0153","volume":"24","author":"T Planck","year":"2014","unstructured":"Planck T, Shahida B, Parikh H, Str\u00f6m K, \u00c5sman P, Brorson H, Hallengren B, Lantz M (2014) Smoking Induces Overexpression of Immediate Early Genes in Active Graves\u2019 Ophthalmopathy. Thyroid 24(10):1524\u20131532. https:\/\/doi.org\/10.1089\/thy.2014.0153","journal-title":"Thyroid"},{"issue":"2","key":"5456_CR12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1089\/thy.2010.0218","volume":"21","author":"NI Regensburg","year":"2011","unstructured":"Regensburg NI, Wiersinga WM, Berendschot TTJM, Saeed P, Mourits MP (2011) Effect of Smoking on Orbital Fat and Muscle Volume in Graves\u2019 Orbitopathy. Thyroid 21(2):177\u2013181. https:\/\/doi.org\/10.1089\/thy.2010.0218","journal-title":"Thyroid"},{"issue":"12","key":"5456_CR13","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1038\/eye.2016.184","volume":"30","author":"A Sadeghi-Tari","year":"2016","unstructured":"Sadeghi-Tari A, Jamshidian-Tehrani M, Nabavi A, Sharif-Kashani S, Elhami E, Hassanpour N, Ameli Zamani K (2016) Effect of smoking on retrobulbar blood flow in thyroid eye disease. Eye (London) 30(12):1573\u20131578. https:\/\/doi.org\/10.1038\/eye.2016.184","journal-title":"Eye (London)"},{"issue":"12","key":"5456_CR14","doi-asserted-by":"publisher","first-page":"E1523","DOI":"10.1210\/jc.2015-2976","volume":"100","author":"N Matheis","year":"2015","unstructured":"Matheis N, Lantz M, Grus FH, Ponto KA, Wolters D, Brorson H, Planck T, Shahida B, Pitz S, Pfeiffer N, Kahaly GJ (2015) Proteomics of Orbital Tissue in Thyroid-Associated Orbitopathy. J Clin Endocrinol Metab 100(12):E1523\u2013E1530. https:\/\/doi.org\/10.1210\/jc.2015-2976","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"5456_CR15","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1136\/bjophthalmol-2014-306463","volume":"99","author":"L Xing","year":"2015","unstructured":"Xing L, Ye L, Zhu W, Shen L, Huang F, Jiao Q, Zhou X, Wang S, Wang W, Ning G (2015) Smoking was associated with poor response to intravenous steroids therapy in Graves\u2019 ophthalmopathy. Brit J Ophthalmol 99(12):1686\u20131691. https:\/\/doi.org\/10.1136\/bjophthalmol-2014-306463","journal-title":"Brit J Ophthalmol"},{"key":"5456_CR16","doi-asserted-by":"publisher","unstructured":"Czarnywojtek A, Komar-Rychlicka K, Zgorzalewicz-Stachowiak M, Sawicka-Gutaj N, Woli\u0144ski K, Gut P, P\u0142azinska M, Torli\u0144ska B, Florek E, Walig\u00f3rska-Stachura J, Rucha\u0142a M (2016) Efficacy and safety of radioiodine therapy for mild Graves ophthalmopathy depending on cigarette consumption: a 6\u2011month follow\u2011up. Polish Archives of Internal Medicine 126(10):746\u2013753. https:\/\/doi.org\/10.20452\/pamw.3505","DOI":"10.20452\/pamw.3505"},{"issue":"4","key":"5456_CR17","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/eye.2016.304","volume":"31","author":"YJ Woo","year":"2017","unstructured":"Woo YJ, Kim JW, Yoon JS (2017) Preoperative clinical features of reactivated of Graves\u2019 orbitopathy after orbital decompression. Eye 31(4):643\u2013649. https:\/\/doi.org\/10.1038\/eye.2016.304","journal-title":"Eye"},{"issue":"11","key":"5456_CR18","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1007\/s40618-016-0484-y","volume":"39","author":"HX Li","year":"2016","unstructured":"Li HX, Xiang N, Hu WK, Jiao XL (2016) Relation between therapy options for Graves\u2019 disease and the course of Graves\u2019 ophthalmopathy: a systematic review and meta-analysis. J Endocrinol Invest 39(11):1225\u20131233. https:\/\/doi.org\/10.1007\/s40618-016-0484-y","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"5456_CR19","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1967\/s002449910606","volume":"20","author":"WL Tay","year":"2017","unstructured":"Tay WL, Tong A, Hui K, Tang Y, Chng CL (2017) Radioiodine associated de novo Graves\u2019 opthalmopathy in an Asian cohort. Hell J Nucl Med 20(3):227\u2013231. https:\/\/doi.org\/10.1967\/s002449910606","journal-title":"Hell J Nucl Med"},{"issue":"7","key":"5456_CR20","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1210\/jc.2014-4542","volume":"100","author":"N Watanabe","year":"2015","unstructured":"Watanabe N, Noh JY, Kozaki A, Iwaku K, Sekiya K, Kosuga Y, Matsumoto M, Suzuki M, Yoshihara A, Ohye H, Kobayashi S, Kunii Y, Mukasa K, Sugino K, Inoue T, Ito K (2015) Radioiodine-Associated Exacerbation of Graves\u2019 Orbitopathy in the Japanese Population: Randomized Prospective Study. J Clin Endocrinol Metab 100(7):2700\u20132708. https:\/\/doi.org\/10.1210\/jc.2014-4542","journal-title":"J Clin Endocrinol Metab"},{"issue":"48","key":"5456_CR21","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005474","volume":"95","author":"C Louvet","year":"2016","unstructured":"Louvet C, De Bellis A, Pereira B, Bournaud C, Kelly A, Maqdasy S, Roche B, Desbiez F, Borson-Chazot F, Tauveron I, Batisse-Lignier M (2016) Time course of Graves\u2019 orbitopathy after total thyroidectomy and radioiodine therapy for thyroid cancer. Medicine 95(48):e5474. https:\/\/doi.org\/10.1097\/MD.0000000000005474","journal-title":"Medicine"},{"issue":"10","key":"5456_CR22","doi-asserted-by":"publisher","first-page":"3700","DOI":"10.1210\/jc.2009-0747","volume":"94","author":"Tra\u0308isk F, Tallstedt L, Abraham-Nor","year":"2009","unstructured":"Tra\u0308isk F, Tallstedt L, Abraham-Nordling M, Andersson T, Berg G, Calissendorff J, Hallengren B, Hedner P, Lantz M, Nystro\u0308m E, Ponjavic V, Taube A, To\u0308rring O, Wallin G, A\u030asman P, Lundell G, Thyroid SGOT, The TSGO, (2009) Thyroid-Associated Ophthalmopathy after Treatment for Graves\u2019 Hyperthyroidism with Antithyroid Drugs or Iodine-131. J Clin Endocrinol Metab 94(10):3700\u20133707. https:\/\/doi.org\/10.1210\/jc.2009-0747","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"5456_CR23","first-page":"241","volume":"34","author":"A Czarnywojtek","year":"2013","unstructured":"Czarnywojtek A, Zgorzalewicz-Stachowiak M, Budny B, Wasko R, Florek E, Szczepanek E, Komar-Rychlicka K, Waligorska-Stachura J, Kurdybacha P, Miechowicz I, Ruchala M (2013) The influence of radioiodine therapy on ocular changes and their relation to urine cotinine level in patients with Graves\u2019 Ophthalmopathy. Neuro Endocrinol Lett 34(3):241\u2013248","journal-title":"Neuro Endocrinol Lett"},{"issue":"6","key":"5456_CR24","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1111\/cen.12392","volume":"80","author":"JJ Khong","year":"2014","unstructured":"Khong JJ, Goldstein RF, Sanders KM, Schneider H, Pope J, Burdon KP, Craig JE, Ebeling PR (2014) Serum selenium status in Graves\u2019 disease with and without orbitopathy: a case-control study. Clin Endocrinol 80(6):905\u2013910. https:\/\/doi.org\/10.1111\/cen.12392","journal-title":"Clin Endocrinol"},{"issue":"6","key":"5456_CR25","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1590\/2359-3997000000309","volume":"61","author":"MAF Federige","year":"2017","unstructured":"Federige MAF, Romaldini JH, Miklos ABPP, Koike MK, Takei K, Portes EDS (2017) Serum selenium and selenoprotein-P levels in autoimmune thyroid diseases patients in a select center: a transversal study. Archives of Endocrinology and Metabolism 61(6):600\u2013607. https:\/\/doi.org\/10.1590\/2359-3997000000309","journal-title":"Archives of Endocrinology and Metabolism"},{"issue":"20","key":"5456_CR26","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1056\/NEJMoa1012985","volume":"364","author":"C Marcocci","year":"2011","unstructured":"Marcocci C, Kahaly GJ, Krassas GE, Bartalena L, Prummel M, Stahl M, Altea MA, Nardi M, Pitz S, Boboridis K, Sivelli P, von Arx G, Mourits MP, Baldeschi L, Bencivelli W, Wiersinga W (2011) Selenium and the Course of Mild Graves\u2019 Orbitopathy. New Engl J Med 364(20):1920\u20131931. https:\/\/doi.org\/10.1056\/NEJMoa1012985","journal-title":"New Engl J Med"},{"issue":"2","key":"5456_CR27","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1007\/s12020-016-1226-9","volume":"58","author":"G Rotondo Dottore","year":"2017","unstructured":"Rotondo Dottore G, Chiarini R, De Gregorio M, Leo M, Casini G, Cestari L, Sellari-Franceschini S, Nardi M, Vitti P, Marcocci C, Marin\u00f2 M (2017) Selenium rescues orbital fibroblasts from cell death induced by hydrogen peroxide: another molecular basis for the effects of selenium in graves\u2019 orbitopathy. Endocrine 58(2):386\u2013389. https:\/\/doi.org\/10.1007\/s12020-016-1226-9","journal-title":"Endocrine"},{"issue":"2","key":"5456_CR28","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1089\/thy.2016.0397","volume":"27","author":"G Rotondo Dottore","year":"2017","unstructured":"Rotondo Dottore G, Leo M, Casini G, Latrofa F, Cestari L, Sellari-Franceschini S, Nardi M, Vitti P, Marcocci C, Marin\u00f2 M (2017) Antioxidant Actions of Selenium in Orbital Fibroblasts: A Basis for the Effects of Selenium in Graves\u2019 Orbitopathy. Thyroid 27(2):271\u2013278. https:\/\/doi.org\/10.1089\/thy.2016.0397","journal-title":"Thyroid"},{"key":"5456_CR29","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.exer.2018.05.022","volume":"174","author":"G Yang","year":"2018","unstructured":"Yang G, Fu Y, Lu X, Wang M, Dong H, Li Q (2018) The interactive effects of genetic polymorphisms within LFA-1\/ICAM-1\/GSK-3\u03b2 pathway and environmental hazards on the development of Graves opthalmopathy. Exp Eye Res 174:161\u2013172. https:\/\/doi.org\/10.1016\/j.exer.2018.05.022","journal-title":"Exp Eye Res"},{"issue":"1","key":"5456_CR30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10654-013-9869-9","volume":"29","author":"M Frisch","year":"2014","unstructured":"Frisch M, Nielsen NM, Pedersen BV (2014) Same-sex marriage, autoimmune thyroid gland dysfunction and other autoimmune diseases in Denmark 1989\u20132008. Eur J Epidemiol 29(1):63\u201371. https:\/\/doi.org\/10.1007\/s10654-013-9869-9","journal-title":"Eur J Epidemiol"},{"issue":"4","key":"5456_CR31","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3109\/13651501.2011.631016","volume":"16","author":"CB Topcu","year":"2012","unstructured":"Topcu CB, Celik O, Tasan E (2012) Effect of stressful life events on the initiation of graves\u2019 disease. Int J Psychiat Clin 16(4):307\u2013311. https:\/\/doi.org\/10.3109\/13651501.2011.631016","journal-title":"Int J Psychiat Clin"},{"issue":"4","key":"5456_CR32","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/j.1365-2265.2005.02352.x","volume":"63","author":"GJ Kahaly","year":"2005","unstructured":"Kahaly GJ, Petrak F, Hardt J, Pitz S, Egle UT (2005) Psychosocial morbidity of Graves\u2019 orbitopathy. Clin Endocrinol (Oxf) 63(4):395\u2013402. https:\/\/doi.org\/10.1111\/j.1365-2265.2005.02352.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"5456_CR33","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.exer.2018.05.022","volume":"174","author":"G Yang","year":"2018","unstructured":"Yang G, Fu Y, Lu X, Wang M, Dong H, Li Q (2018) The interactive effects of genetic polymorphisms within LFA-1\/ICAM-1\/GSK-3\u03b2 pathway and environmental hazards on the development of Graves\u2019 opthalmopathy. Exp Eye Res 174:161\u2013172. https:\/\/doi.org\/10.1016\/j.exer.2018.05.022","journal-title":"Exp Eye Res"},{"issue":"3","key":"5456_CR34","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/IOP.0000000000000077","volume":"30","author":"MR Edmunds","year":"2014","unstructured":"Edmunds MR, Huntbach JA, Durrani OM (2014) Are Ethnicity, Social Grade, and Social Deprivation Associated With Severity of Thyroid-Associated Ophthalmopathy? Ophthalmic Plast Reconstr Surg 30(3):241\u2013245. https:\/\/doi.org\/10.1097\/IOP.0000000000000077","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"5456_CR35","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.clim.2017.07.001","volume":"183","author":"HL K\u00f6hling","year":"2017","unstructured":"K\u00f6hling HL, Plummer SF, Marchesi JR, Davidge KS, Ludgate M (2017) The microbiota and autoimmunity: Their role in thyroid autoimmune diseases. Clin Immunol 183:63\u201374. https:\/\/doi.org\/10.1016\/j.clim.2017.07.001","journal-title":"Clin Immunol"},{"issue":"6","key":"5456_CR36","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/j.1523-5378.2010.00802.x","volume":"15","author":"V Bassi","year":"2010","unstructured":"Bassi V, Santinelli C, Iengo A, Romano C (2010) Identification of a Correlation between Helicobacter pylori Infection and Graves\u2019 Disease. Helicobacter 15(6):558\u2013562. https:\/\/doi.org\/10.1111\/j.1523-5378.2010.00802.x","journal-title":"Helicobacter"},{"issue":"11","key":"5456_CR37","doi-asserted-by":"publisher","first-page":"5373","DOI":"10.4049\/jimmunol.1203412","volume":"190","author":"CE Hargreaves","year":"2013","unstructured":"Hargreaves CE, Grasso M, Hampe CS, Stenkova A, Atkinson S, Joshua GWP, Wren BW, Buckle AM, Dunn-Walters D, Banga JP (2013) Yersinia enterocolitica Provides the Link between Thyroid-Stimulating Antibodies and Their Germline Counterparts in Graves\u2019 Disease. J Immunol 190(11):5373\u20135381. https:\/\/doi.org\/10.4049\/jimmunol.1203412","journal-title":"J Immunol"},{"issue":"2","key":"5456_CR38","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1677\/jme.0.0080137","volume":"8","author":"GC Huang","year":"1992","unstructured":"Huang GC, Collison KS, McGregor AM, Banga JP (1992) Expression of a human thyrotrophin receptor fragment in Escherichia coli and its interaction with the hormone and autoantibodies from patients with Graves\u2019 disease. J Mol Endocrinol 8(2):137\u2013144. https:\/\/doi.org\/10.1677\/jme.0.0080137","journal-title":"J Mol Endocrinol"},{"issue":"8","key":"5456_CR39","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1007\/s40618-019-1010-9","volume":"42","author":"TT Shi","year":"2019","unstructured":"Shi TT, Xin Z, Hua L, Zhao RX, Yang YL, Wang H, Zhang S, Liu W, Xie RR (2019) Alterations in the intestinal microbiota of patients with severe and active Graves\u2019 orbitopathy: a cross-sectional study. J Endocrinol Invest 42(8):967\u2013978. https:\/\/doi.org\/10.1007\/s40618-019-1010-9","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"5456_CR40","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s40168-018-0478-4","volume":"6","author":"G Masetti","year":"2018","unstructured":"Masetti G, Moshkelgosha S, Kohling HL, Covelli D, Banga JP, Berchner-Pfannschmidt U, Horstmann M, Diaz-Cano S, Goertz GE, Plummer S, Eckstein A, Ludgate M, Biscarini F, Marchesi JR (2018) Gut microbiota in experimental murine model of Graves\u2019 orbitopathy established in different environments may modulate clinical presentation of disease. Microbiome 6(1):97. https:\/\/doi.org\/10.1186\/s40168-018-0478-4","journal-title":"Microbiome"},{"issue":"2","key":"5456_CR41","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1097\/00006842-199803000-00013","volume":"60","author":"K Yoshiuchi","year":"1998","unstructured":"Yoshiuchi K, Kumano H, Nomura S, Yoshimura H, Ito K, Kanaji Y, Ohashi Y, Kuboki T, Suematsu H (1998) Stressful Life Events and Smoking Were Associated With Graves\u2019 Disease in Women, but Not in Men. Psychosom Med 60(2):182\u2013185. https:\/\/doi.org\/10.1097\/00006842-199803000-00013","journal-title":"Psychosom Med"},{"issue":"6","key":"5456_CR42","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3341\/kjo.2013.27.6.397","volume":"27","author":"KI Woo","year":"2013","unstructured":"Woo KI, Kim Y, Lee SY (2013) Prevalence and Risk Factors for Thyroid Eye Disease among Korean Dysthyroid Patients. Korean J Ophthalmol 27(6):397. https:\/\/doi.org\/10.3341\/kjo.2013.27.6.397","journal-title":"Korean J Ophthalmol"},{"issue":"12","key":"5456_CR43","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1089\/thy.2008.0044","volume":"18","author":"SL Lim","year":"2008","unstructured":"Lim SL, Lim AKE, Mumtaz M, Hussein E, Wan Bebakar WM, Khir AS (2008) Prevalence, Risk Factors, and Clinical Features of Thyroid-Associated Ophthalmopathy in Multiethnic Malaysian Patients with Graves\u2019 Disease. Thyroid 18(12):1297\u20131301. https:\/\/doi.org\/10.1089\/thy.2008.0044","journal-title":"Thyroid"},{"issue":"1","key":"5456_CR44","doi-asserted-by":"publisher","first-page":"13096","DOI":"10.1038\/s41598-018-31253-4","volume":"8","author":"A Schl\u00fcter","year":"2018","unstructured":"Schl\u00fcter A, Fl\u00f6gel U, Diaz-Cano S, G\u00f6rtz G, St\u00e4hr K, Oeverhaus M, Pl\u00f6hn S, Mattheis S, Moeller LC, Lang S, Bechrakis NE, Banga JP, Eckstein A, Berchner-Pfannschmidt U (2018) Graves\u2019 orbitopathy occurs sex-independently in an autoimmune hyperthyroid mouse model. Sci Rep-Uk 8(1):13096. https:\/\/doi.org\/10.1038\/s41598-018-31253-4","journal-title":"Sci Rep-Uk"},{"issue":"6","key":"5456_CR45","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1097\/ICU.0000000000000529","volume":"29","author":"Z Li","year":"2018","unstructured":"Li Z, Cestari DM, Fortin E (2018) Thyroid eye disease. Curr Opin Ophthalmol 29(6):528\u2013534. https:\/\/doi.org\/10.1097\/ICU.0000000000000529","journal-title":"Curr Opin Ophthalmol"},{"issue":"11","key":"5456_CR46","doi-asserted-by":"publisher","first-page":"823","DOI":"10.3760\/cma.j.issn.0578-1426.2019.11.007","volume":"58","author":"XZ Ye","year":"2019","unstructured":"Ye XZ, Huang SS, Liu J, Lu B, Shao JQ (2019) High serum cholesterol: a novel risk factor for thyroid associated ophthalmopathy? Zhonghua Nei Ke Za Zhi 58(11):823\u2013825. https:\/\/doi.org\/10.3760\/cma.j.issn.0578-1426.2019.11.007","journal-title":"Zhonghua Nei Ke Za Zhi"},{"issue":"12","key":"5456_CR47","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1007\/s40618-018-0915-z","volume":"41","author":"G Lanzolla","year":"2018","unstructured":"Lanzolla G, Sabini E, Profilo MA, Mazzi B, Sframeli A, Rocchi R, Menconi F, Leo M, Nardi M, Vitti P, Marcocci C, Marin\u00f2 M (2018) Relationship between serum cholesterol and Graves\u2019 orbitopathy (GO): a confirmatory study. J Endocrinol Invest 41(12):1417\u20131423. https:\/\/doi.org\/10.1007\/s40618-018-0915-z","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"5456_CR48","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1089\/thy.2017.0430","volume":"28","author":"E Sabini","year":"2018","unstructured":"Sabini E, Mazzi B, Profilo MA, Mautone T, Casini G, Rocchi R, Ionni I, Menconi F, Leo M, Nardi M, Vitti P, Marcocci C, Marin\u00f2 M (2018) High Serum Cholesterol Is a Novel Risk Factor for Graves\u2019 Orbitopathy: Results of a Cross-Sectional Study. Thyroid 28(3):386\u2013394. https:\/\/doi.org\/10.1089\/thy.2017.0430","journal-title":"Thyroid"},{"key":"5456_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.609895","volume":"11","author":"A Naselli","year":"2020","unstructured":"Naselli A, Moretti D, Regalbuto C, Arpi ML, Lo GF, Frasca F, Belfiore A, Le Moli R (2020) Evidence That Baseline Levels of Low-Density Lipoproteins Cholesterol Affect the Clinical Response of Graves\u2019 Ophthalmopathy to Parenteral Corticosteroids. Front Endocrinol (Lausanne) 11:609895. https:\/\/doi.org\/10.3389\/fendo.2020.609895","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"5456_CR50","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/eye.2017.42","volume":"31","author":"B Sun","year":"2017","unstructured":"Sun B, Zhang Z, Dong C, Zhang Y, Yan C, Li S (2017) 99Tcm-octreotide scintigraphy and serum eye muscle antibodies in evaluation of active thyroid-associated ophthalmopathy. Eye 31(5):668\u2013676. https:\/\/doi.org\/10.1038\/eye.2017.42","journal-title":"Eye"},{"issue":"2","key":"5456_CR51","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s12519-014-0476-y","volume":"10","author":"JH Lee","year":"2014","unstructured":"Lee JH, Park SH, Koh DG, Suh BK (2014) Thyroid peroxidase antibody positivity and triiodothyronine levels are associated with pediatric Graves\u2019 ophthalmopathy. World J Pediatr 10(2):155\u2013159. https:\/\/doi.org\/10.1007\/s12519-014-0476-y","journal-title":"World J Pediatr"},{"issue":"4","key":"5456_CR52","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s40618-018-0943-8","volume":"42","author":"M Marin\u00f2","year":"2019","unstructured":"Marin\u00f2 M, Rotondo Dottore G, Ionni I, Lanzolla G, Sabini E, Ricci D, Sframeli A, Mazzi B, Menconi F, Latrofa F, Vitti P, Marcocci C, Chiovato L (2019) Serum antibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves\u2019 disease and Graves\u2019 orbitopathy. J Endocrinol Invest 42(4):471\u2013480. https:\/\/doi.org\/10.1007\/s40618-018-0943-8","journal-title":"J Endocrinol Invest"},{"issue":"4S","key":"5456_CR53","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1097\/IOP.0000000000001053","volume":"34","author":"T Diana","year":"2018","unstructured":"Diana T, Kahaly GJ (2018) Thyroid Stimulating Hormone Receptor Antibodies in Thyroid Eye Disease\u2014Methodology and Clinical Applications. Ophthalmic Plast Reconstr Surg 34(4S):S13\u2013S19. https:\/\/doi.org\/10.1097\/IOP.0000000000001053","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"02","key":"5456_CR54","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1055\/s-0033-1363193","volume":"122","author":"M Lantz","year":"2014","unstructured":"Lantz M, Planck T, \u00c5sman P, Hallengren B (2014) Increased TRAb and\/or Low Anti-TPO Titers at Diagnosis of Graves\u2019 Disease are Associated with an Increased Risk of Developing Ophthalmopathy after Onset. Exp Clin Endocr Diab 122(02):113\u2013117. https:\/\/doi.org\/10.1055\/s-0033-1363193","journal-title":"Exp Clin Endocr Diab"},{"issue":"9","key":"5456_CR55","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1089\/thy.2017.0126","volume":"27","author":"SH Yu","year":"2017","unstructured":"Yu SH, Kang JG, Kim CS, Ihm S, Choi MG, Yoo HJ, Lee SJ (2017) Clinical Implications of Immunoglobulin G4 to Graves\u2019 Ophthalmopathy. Thyroid 27(9):1185\u20131193. https:\/\/doi.org\/10.1089\/thy.2017.0126","journal-title":"Thyroid"},{"issue":"6","key":"5456_CR56","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1530\/EJE-18-0039","volume":"178","author":"W Wiersinga","year":"2018","unstructured":"Wiersinga W, \u017darkovi\u0107 M, Bartalena L, Donati S, Perros P, Okosieme O, Morris D, Fichter N, Lareida J, von Arx G, Daumerie C, Burlacu M, Kahaly G, Pitz S, Beleslin B, \u0106iri\u0107 J, Ayvaz G, Konuk O, T\u00f6r\u00fcner FB, Salvi M, Covelli D, Curro N, Heged\u00fcs L, Brix T (2018) Predictive score for the development or progression of Graves\u2019 orbitopathy in patients with newly diagnosed Graves\u2019 hyperthyroidism. Eur J Endocrinol 178(6):635\u2013643. https:\/\/doi.org\/10.1530\/EJE-18-0039","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"5456_CR57","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1136\/bjo.2007.137265","volume":"93","author":"AK Eckstein","year":"2009","unstructured":"Eckstein AK, Losch C, Glowacka D, Schott M, Mann K, Esser J, Morgenthaler NG (2009) Euthyroid and primarily hypothyroid patients develop milder and significantly more asymmetrical Graves ophthalmopathy. Brit J Ophthalmol 93(8):1052\u20131056. https:\/\/doi.org\/10.1136\/bjo.2007.137265","journal-title":"Brit J Ophthalmol"},{"issue":"5","key":"5456_CR58","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1507\/endocrj.52.505","volume":"52","author":"K Shibayama","year":"2005","unstructured":"Shibayama K, Ohyama Y, Yokota Y, Ohtsu S, Takubo N, MATSUURA N, (2005) Assays for Thyroid-stimulating Antibodies and Thyrotropin-binding Inhibitory Immunoglobulins in Children with Graves\u2019 Disease. Endocr J 52(5):505\u2013510. https:\/\/doi.org\/10.1507\/endocrj.52.505","journal-title":"Endocr J"},{"issue":"9","key":"5456_CR59","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.1210\/jc.2005-2813","volume":"91","author":"AK Eckstein","year":"2006","unstructured":"Eckstein AK, Plicht M, Lax H, Neuha\u0308user M, Mann K, Lederbogen S, Heckmann C, Esser J, Morgenthaler NG, (2006) Thyrotropin Receptor Autoantibodies Are Independent Risk Factors for Graves\u2019 Ophthalmopathy and Help to Predict Severity and Outcome of the Disease. J Clin Endocrinol Metab 91(9):3464\u20133470. https:\/\/doi.org\/10.1210\/jc.2005-2813","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"5456_CR60","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1210\/jc.2013-1149","volume":"98","author":"AF Turcu","year":"2013","unstructured":"Turcu AF, Kumar S, Neumann S, Coenen M, Iyer S, Chiriboga P, Gershengorn MC, Bahn RS (2013) A Small Molecule Antagonist Inhibits Thyrotropin Receptor Antibody-Induced Orbital Fibroblast Functions Involved in the Pathogenesis of Graves Ophthalmopathy. J Clin Endocrinol Metab 98(5):2153\u20132159. https:\/\/doi.org\/10.1210\/jc.2013-1149","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"5456_CR61","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1089\/thy.2010.0123","volume":"21","author":"CJJ van Zeijl","year":"2011","unstructured":"van Zeijl CJJ, Fliers E, van Koppen CJ, Surovtseva OV, de Gooyer ME, Mourits MP, Wiersinga WM, Miltenburg AMM, Boelen A (2011) Thyrotropin Receptor-Stimulating Graves\u2019 Disease Immunoglobulins Induce Hyaluronan Synthesis by Differentiated Orbital Fibroblasts from Patients with Graves\u2019 Ophthalmopathy Not Only Via Cyclic Adenosine Monophosphate Signaling Pathways. Thyroid 21(2):169\u2013176. https:\/\/doi.org\/10.1089\/thy.2010.0123","journal-title":"Thyroid"},{"issue":"5","key":"5456_CR62","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1210\/jc.2011-2890","volume":"97","author":"S Kumar","year":"2012","unstructured":"Kumar S, Iyer S, Bauer H, Coenen M, Bahn RS (2012) A Stimulatory Thyrotropin Receptor Antibody Enhances Hyaluronic Acid Synthesis in Graves\u2019 Orbital Fibroblasts: Inhibition by an IGF-I Receptor Blocking Antibody. J Clin Endocrinol Metab 97(5):1681\u20131687. https:\/\/doi.org\/10.1210\/jc.2011-2890","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"5456_CR63","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1210\/jc.2016-1315","volume":"101","author":"CC Krieger","year":"2016","unstructured":"Krieger CC, Place RF, Bevilacqua C, Marcus-Samuels B, Abel BS, Skarulis MC, Kahaly GJ, Neumann S, Gershengorn MC (2016) TSH\/IGF-1 Receptor Cross Talk in Graves\u2019 Ophthalmopathy Pathogenesis. J Clin Endocrinol Metab 101(6):2340\u20132347. https:\/\/doi.org\/10.1210\/jc.2016-1315","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"5456_CR64","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/bph.13693","volume":"174","author":"RF Place","year":"2017","unstructured":"Place RF, Krieger CC, Neumann S, Gershengorn MC (2017) Inhibiting thyrotropin\/insulin-like growth factor 1 receptor crosstalk to treat Graves\u2019 ophthalmopathy: studies in orbital fibroblastsin vitro. Brit J Pharmacol 174(4):328\u2013340. https:\/\/doi.org\/10.1111\/bph.13693","journal-title":"Brit J Pharmacol"},{"issue":"6","key":"5456_CR65","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1210\/en.2019-00055","volume":"160","author":"CC Krieger","year":"2019","unstructured":"Krieger CC, Boutin A, Jang D, Morgan SJ, Banga JP, Kahaly GJ, Klubo-Gwiezdzinska J, Neumann S, Gershengorn MC (2019) Arrestin-\u03b2-1 Physically Scaffolds TSH and IGF1 Receptors to Enable Crosstalk. Endocrinology 160(6):1468\u20131479. https:\/\/doi.org\/10.1210\/en.2019-00055","journal-title":"Endocrinology"},{"issue":"1","key":"5456_CR66","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1089\/thy.2009.0278","volume":"20","author":"S Kumar","year":"2010","unstructured":"Kumar S, Schiefer R, Coenen MJ, Bahn RS (2010) A Stimulatory Thyrotropin Receptor Antibody (M22) and Thyrotropin Increase Interleukin-6 Expression and Secretion in Graves\u2019 Orbital Preadipocyte Fibroblasts. Thyroid 20(1):59\u201365. https:\/\/doi.org\/10.1089\/thy.2009.0278","journal-title":"Thyroid"},{"issue":"6","key":"5456_CR67","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s00417-017-3894-4","volume":"256","author":"K Cheng","year":"2018","unstructured":"Cheng K, Wu Y, Cheng K, Cheng K, Chen K, Wu W, Lee P, Chang C (2018) Autoantibody against aldehyde dehydrogenase 2 could be a biomarker to monitor progression of Graves\u2019 orbitopathy. Graefes Arch Clin Exp Ophthalmol 256(6):1195\u20131201. https:\/\/doi.org\/10.1007\/s00417-017-3894-4","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"8","key":"5456_CR68","doi-asserted-by":"publisher","first-page":"698","DOI":"10.3109\/08916931003774954","volume":"43","author":"S de Haan","year":"2010","unstructured":"de Haan S, Lahooti H, Morris O, Wall JR (2010) Epitopes, immunoglobulin classes and immunoglobulin G subclasses of calsequestrin antibodies in patients with thyroid eye disease. Autoimmunity 43(8):698\u2013703. https:\/\/doi.org\/10.3109\/08916931003774954","journal-title":"Autoimmunity"},{"issue":"9","key":"5456_CR69","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1007\/s40618-021-01505-8","volume":"44","author":"S Khamisi","year":"2021","unstructured":"Khamisi S, Lundqvist M, Emadi P, Almby K, Ljunggren O, Karlsson FA (2021) Serum thyroglobulin is associated with orbitopathy in Graves\u2019 disease. J Endocrinol Invest 44(9):1905\u20131911. https:\/\/doi.org\/10.1007\/s40618-021-01505-8","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"5456_CR70","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/jhg.2016.135","volume":"62","author":"A Ku\u015b","year":"2017","unstructured":"Ku\u015b A, Szyma\u0144ski K, Jurecka-Lubieniecka B, Pawlak-Adamska E, Kula D, Mi\u015bkiewicz P, Bolanowski M, P\u0142oski R, Bossowski A, Daroszewski J, Jarz\u0105b B, Bednarczuk T (2017) Gender-dependent and age-of-onset-specific association of the rs11675434 single-nucleotide polymorphism near TPO with susceptibility to Graves\u2019 ophthalmopathy. J Hum Genet 62(3):373\u2013377. https:\/\/doi.org\/10.1038\/jhg.2016.135","journal-title":"J Hum Genet"},{"issue":"1","key":"5456_CR71","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1089\/thy.2012.0379","volume":"23","author":"MA Profilo","year":"2013","unstructured":"Profilo MA, Sisti E, Marcocci C, Vitti P, Pinchera A, Nardi M, Rocchi R, Latrofa F, Menconi F, Altea MA, Leo M, Rago T, Marin\u00f2 M (2013) Thyroid Volume and Severity of Graves\u2019 Orbitopathy. Thyroid 23(1):97\u2013102. https:\/\/doi.org\/10.1089\/thy.2012.0379","journal-title":"Thyroid"},{"issue":"5","key":"5456_CR72","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.3349\/ymj.2015.56.5.1389","volume":"56","author":"SY Jang","year":"2015","unstructured":"Jang SY, Lee KH, Oh JR, Kim BY, Yoon JS (2015) Development of Thyroid-Associated Ophthalmopathy in Patients Who Underwent Total Thyroidectomy. Yonsei Med J 56(5):1389. https:\/\/doi.org\/10.3349\/ymj.2015.56.5.1389","journal-title":"Yonsei Med J"},{"issue":"5","key":"5456_CR73","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1210\/jc.2006-1800","volume":"92","author":"F Menconi","year":"2007","unstructured":"Menconi F, Marino\u0300 M, Pinchera A, Rocchi R, Mazzi B, Nardi M, Bartalena L, Marcocci C, (2007) Effects of Total Thyroid Ablation Versus Near-Total Thyroidectomy Alone on Mild to Moderate Graves\u2019 Orbitopathy Treated with Intravenous Glucocorticoids. J Clin Endocrinol Metab 92(5):1653\u20131658. https:\/\/doi.org\/10.1210\/jc.2006-1800","journal-title":"J Clin Endocrinol Metab"},{"key":"5456_CR74","doi-asserted-by":"publisher","unstructured":"Stan MN, Durski JM, Brito JP, Bhagra S, Thapa P, Bahn RS (2013) Cohort Study on Radioactive Iodine\u2013Induced Hypothyroidism: Implications for Graves' Ophthalmopathy and Optimal Timing for Thyroid Hormone Assessment. Thyroid (New York, N.Y.) 23(5):62\u2013625. https:\/\/doi.org\/10.1089\/thy.2012.0258","DOI":"10.1089\/thy.2012.0258"},{"issue":"3","key":"5456_CR75","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1210\/jc.2016-2762","volume":"102","author":"R Fernando","year":"2017","unstructured":"Fernando R, Placzek E, Reese EA, Placzek AT, Schwartz S, Trierweiler A, Niziol LM, Raychaudhuri N, Atkins S, Scanlan TS, Smith TJ (2017) Elevated Serum Tetrac in Graves Disease: Potential Pathogenic Role in Thyroid-Associated Ophthalmopathy. J Clin Endocrinol Metab 102(3):776\u2013785. https:\/\/doi.org\/10.1210\/jc.2016-2762","journal-title":"J Clin Endocrinol Metab"},{"key":"5456_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/8129497","volume":"2016","author":"D Jarusaitiene","year":"2016","unstructured":"Jarusaitiene D, Verkauskiene R, Jasinskas V, Jankauskiene J (2016) Predictive Factors of Development of Graves\u2019 Ophthalmopathy for Patients with Juvenile Graves\u2019 Disease. Int J Endocrinol 2016:1\u20139. https:\/\/doi.org\/10.1155\/2016\/8129497","journal-title":"Int J Endocrinol"},{"issue":"4","key":"5456_CR77","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1056\/NEJMoa1910434","volume":"382","author":"RS Douglas","year":"2020","unstructured":"Douglas RS, Kahaly GJ, Patel A, Sile S, Thompson EHZ, Perdok R, Fleming JC, Fowler BT, Marcocci C, Marin\u00f2 M, Antonelli A, Dailey R, Harris GJ, Eckstein A, Schiffman J, Tang R, Nelson C, Salvi M, Wester S, Sherman JW, Vescio T, Holt RJ, Smith TJ (2020) Teprotumumab for the Treatment of Active Thyroid Eye Disease. New Engl J Med 382(4):341\u2013352. https:\/\/doi.org\/10.1056\/NEJMoa1910434","journal-title":"New Engl J Med"},{"issue":"7","key":"5456_CR78","first-page":"302","volume":"69","author":"MR Soeters","year":"2011","unstructured":"Soeters MR, van Zeijl CJ, Boelen A, Kloos R, Saeed P, Vriesendorp TM, Mourits MP (2011) Optimal management of Graves orbitopathy: a multidisciplinary approach. Neth J Med 69(7):302\u2013308","journal-title":"Neth J Med"},{"issue":"1","key":"5456_CR79","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s12020-016-1096-1","volume":"55","author":"E Pawlak-Adamska","year":"2017","unstructured":"Pawlak-Adamska E, Frydecka I, Bolanowski M, Tomkiewicz A, Jonkisz A, Karabon L, Partyka A, Nowak O, Szalinski M, Daroszewski J (2017) CD28\/CTLA-4\/ICOS haplotypes confers susceptibility to Graves\u2019 disease and modulates clinical phenotype of disease. Endocrine 55(1):186\u2013199. https:\/\/doi.org\/10.1007\/s12020-016-1096-1","journal-title":"Endocrine"},{"issue":"11","key":"5456_CR80","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.3390\/jcm8111842","volume":"8","author":"D Chen","year":"2019","unstructured":"Chen D, Chu Y, Wen Y, Lin W, Hour A, Wang W (2019) Investigation of the Correlation between Graves\u2019 Ophthalmopathy and CTLA4 Gene Polymorphism. J Clin Med 8(11):1842. https:\/\/doi.org\/10.3390\/jcm8111842","journal-title":"J Clin Med"},{"issue":"11","key":"5456_CR81","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1631\/jzus.2006.B0887","volume":"7","author":"Q Zhang","year":"2006","unstructured":"Zhang Q, Yang YM, Lv XY (2006) Association of Graves\u2019 disease and Graves\u2019 ophthalmopathy with the polymorphisms in promoter and exon 1 of cytotoxic T lymphocyte associated antigen-4 gene. J Zhejiang Univ Sci B 7(11):887\u2013891. https:\/\/doi.org\/10.1631\/jzus.2006.B0887","journal-title":"J Zhejiang Univ Sci B"},{"issue":"8","key":"5456_CR82","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1016\/j.ophtha.2009.12.037","volume":"117","author":"Y Liu","year":"2010","unstructured":"Liu Y, Chen R, Chen W, Tsai Y, Wan L, Tsai F (2010) Disease Association of the CD103 Polymorphisms in Taiwan Chinese Graves\u2019 Ophthalmopathy Patients. Ophthalmology 117(8):1645\u20131651. https:\/\/doi.org\/10.1016\/j.ophtha.2009.12.037","journal-title":"Ophthalmology"},{"issue":"3","key":"5456_CR83","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.ophtha.2010.07.021","volume":"118","author":"W Liao","year":"2011","unstructured":"Liao W, Chen R, Lin H, Liu Y, Chen W, Tsai Y, Wan L, Tsai F (2011) The Association between Polymorphisms of B7 Molecules (CD80 and CD86) and Graves\u2019 Ophthalmopathy in a Taiwanese Population. Ophthalmology 118(3):553\u2013557. https:\/\/doi.org\/10.1016\/j.ophtha.2010.07.021","journal-title":"Ophthalmology"},{"issue":"1","key":"5456_CR84","doi-asserted-by":"publisher","first-page":"16672","DOI":"10.1038\/srep16672","volume":"5","author":"KH Wong","year":"2015","unstructured":"Wong KH, Rong SS, Chong KKL, Young AL, Pang CP, Chen LJ (2015) Genetic Associations of Interleukin-related Genes with Graves\u2019 Ophthalmopathy: a Systematic Review and Meta-analysis. Sci Rep-Uk 5(1):16672. https:\/\/doi.org\/10.1038\/srep16672","journal-title":"Sci Rep-Uk"},{"issue":"6","key":"5456_CR85","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/j.1442-9071.2009.02093.x","volume":"37","author":"O Khalilzadeh","year":"2009","unstructured":"Khalilzadeh O, Anvari M, Esteghamati A, Mahmoudi M, Tahvildari M, Rashidi A, Khosravi F, Amirzargar A (2009) Graves\u2019 ophthalmopathy and gene polymorphisms in interleukin-1\u03b1, interleukin-1\u03b2, interleukin-1 receptor and interleukin-1 receptor antagonist. Clin Experiment Ophthalmol 37(6):614\u2013619. https:\/\/doi.org\/10.1111\/j.1442-9071.2009.02093.x","journal-title":"Clin Experiment Ophthalmol"},{"issue":"3","key":"5456_CR86","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1007\/s12020-009-9240-9","volume":"36","author":"L Gu","year":"2009","unstructured":"Gu L, Jia H, Zhao Y, Liu N, Wang S, Cui B, Ning G (2009) Association studies of interleukin-8 gene in Graves\u2019 disease and Graves\u2019 ophthalmopathy. Endocrine 36(3):452\u2013456. https:\/\/doi.org\/10.1007\/s12020-009-9240-9","journal-title":"Endocrine"},{"issue":"6","key":"5456_CR87","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1038\/eye.2009.244","volume":"24","author":"M Anvari","year":"2010","unstructured":"Anvari M, Khalilzadeh O, Esteghamati A, Esfahani SA, Rashidi A, Etemadi A, Mahmoudi M, Amirzargar AA (2010) Genetic susceptibility to Graves\u2019 ophthalmopathy: the role of polymorphisms in proinflammatory cytokine genes. Eye 24(6):1058\u20131063. https:\/\/doi.org\/10.1038\/eye.2009.244","journal-title":"Eye"},{"issue":"10","key":"5456_CR88","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/BF03346682","volume":"33","author":"W Zhu","year":"2010","unstructured":"Zhu W, Liu N, Zhao Y, Jia H, Cui B, Ning G (2010) Association analysis of polymorphisms in IL-3, IL-4, IL-5, IL-9, and IL-13 with Graves\u2019 disease. J Endocrinol Invest 33(10):751\u2013755. https:\/\/doi.org\/10.1007\/BF03346682","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"5456_CR89","doi-asserted-by":"publisher","first-page":"3338","DOI":"10.4238\/2011.October.31.6","volume":"10","author":"HY Jia","year":"2011","unstructured":"Jia HY, Zhang ZG, Gu XJ, Guo T, Cui B, Ning G, Zhao YJ (2011) Association between interleukin 21 and Graves\u2019 disease. Genet Mol Res 10(4):3338\u20133346. https:\/\/doi.org\/10.4238\/2011.October.31.6","journal-title":"Genet Mol Res"},{"key":"5456_CR90","doi-asserted-by":"crossref","unstructured":"Yang H, Wang Y, Bao J, Wang S, Lei P, Sun Z (2017) Correlation of HLA-DQ and TNF-\u03b1 gene polymorphisms with ocular myasthenia gravis combined with thyroid-associated ophthalmopathy. Bioscience Rep 37(2)10.1042\/BSR20160440","DOI":"10.1042\/BSR20160440"},{"issue":"9","key":"5456_CR91","first-page":"786","volume":"41","author":"SL Yan","year":"2005","unstructured":"Yan SL, Wang YX (2005) The relevance of tumor necrosis factor-alpha gene-863C\/A polymorphism with thyroid-associated ophthalmopathy. Zhonghua Yan Ke Za Zhi 41(9):786\u2013790","journal-title":"Zhonghua Yan Ke Za Zhi"},{"issue":"1","key":"5456_CR92","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/1471-2350-13-116","volume":"13","author":"K Tsai","year":"2012","unstructured":"Tsai K, Tsai F, Lin H, Lin H, Liu Y, Liao W, Wan L (2012) Thymic stromal lymphopoietin gene promoter polymorphisms and expression levels in Graves\u2019 disease and Graves\u2019 ophthalmopathy. Bmc Med Genet 13(1):116. https:\/\/doi.org\/10.1186\/1471-2350-13-116","journal-title":"Bmc Med Genet"},{"issue":"5","key":"5456_CR93","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s40618-014-0228-9","volume":"38","author":"NE Bufalo","year":"2015","unstructured":"Bufalo NE, Dos Santos RB, Marcello MA, Piai RP, Secolin R, Romaldini JH, Ward LS (2015) TSHR intronic polymorphisms (rs179247 and rs12885526) and their role in the susceptibility of the Brazilian population to Graves\u2019 disease and Graves\u2019 ophthalmopathy. J Endocrinol Invest 38(5):555\u2013561. https:\/\/doi.org\/10.1007\/s40618-014-0228-9","journal-title":"J Endocrinol Invest"},{"issue":"7","key":"5456_CR94","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00251-013-0702-0","volume":"65","author":"E Pawlak-Adamska","year":"2013","unstructured":"Pawlak-Adamska E, Daroszewski J, Bolanowski M, Oficjalska J, Janusz P, Szalinski M, Frydecka I (2013) PPARg2 Ala12 variant protects against Graves\u2019 orbitopathy and modulates the course of the disease. Immunogenetics 65(7):493\u2013500. https:\/\/doi.org\/10.1007\/s00251-013-0702-0","journal-title":"Immunogenetics"},{"issue":"3","key":"5456_CR95","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.3892\/mmr.2016.5458","volume":"14","author":"JY Lee","year":"2016","unstructured":"Lee JY, Kim NK, Cho YW, Lew H (2016) Association between methylenetetrahydrofolate reductase (MTHFR) polymorphisms and susceptibility to Graves\u2019 ophthalmopathy. Mol Med Rep 14(3):2276\u20132282. https:\/\/doi.org\/10.3892\/mmr.2016.5458","journal-title":"Mol Med Rep"},{"issue":"6","key":"5456_CR96","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1139\/cjpp-2016-0332","volume":"96","author":"T Wu","year":"2018","unstructured":"Wu T, Tang D, Zhao L, Sun F (2018) Poly (ADP-ribose) polymerase-1 (PARP-1) in Chinese patients with Graves\u2019 disease and Graves\u2019 ophthalmopathy. Can J Physiol Pharm 96(6):556\u2013561. https:\/\/doi.org\/10.1139\/cjpp-2016-0332","journal-title":"Can J Physiol Pharm"},{"issue":"2","key":"5456_CR97","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.gene.2014.06.038","volume":"547","author":"M Niyazoglu","year":"2014","unstructured":"Niyazoglu M, Baykara O, Koc A, Aydo\u011fdu P, Onaran I, Dellal FD, Tasan E, Sultuybek GK (2014) Association of PARP-1, NF-\u03baB, NF-\u03baBIA and IL-6, IL-1\u03b2 and TNF-\u03b1 with Graves Disease and Graves Ophthalmopathy. Gene 547(2):226\u2013232. https:\/\/doi.org\/10.1016\/j.gene.2014.06.038","journal-title":"Gene"},{"issue":"10","key":"5456_CR98","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1016\/j.ophtha.2014.04.027","volume":"121","author":"Y Liu","year":"2014","unstructured":"Liu Y, Chen Y, Wu H, Wang T, Tsai F (2014) Single Nucleotide Polymorphisms at the PRR3, ABCF1, and GNL1 Genes in the HLA Class I Region Are Associated with Graves\u2019 Ophthalmopathy in a Gender-Dependent Manner. Ophthalmology 121(10):2033\u20132039. https:\/\/doi.org\/10.1016\/j.ophtha.2014.04.027","journal-title":"Ophthalmology"},{"issue":"7","key":"5456_CR99","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1167\/iovs.15-18797","volume":"57","author":"JJ Khong","year":"2016","unstructured":"Khong JJ, Burdon KP, Lu Y, Leonardos L, Laurie KJ, Walsh JP, Gajdatsy AD, Ebeling PR, McNab AA, Hardy TG, Stawell RJ, Davis GJ, Selva D, Tsirbas A, Montgomery GW, Macgregor S, Craig JE (2016) Association of Polymorphisms in MACRO Domain Containing 2 With Thyroid-Associated Orbitopathy. Investigative Opthalmology & Visual Science 57(7):3129. https:\/\/doi.org\/10.1167\/iovs.15-18797","journal-title":"Investigative Opthalmology & Visual Science"},{"issue":"6","key":"5456_CR100","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1136\/jclinpath-2014-202751","volume":"68","author":"R Yan","year":"2015","unstructured":"Yan R, Yang J, Jiang P, Jin L, Ma J, Huang R, Ma N, Jiang F (2015) Genetic variations in the SOCS3 gene in patients with Graves\u2019 ophthalmopathy. J Clin Pathol 68(6):448\u2013452. https:\/\/doi.org\/10.1136\/jclinpath-2014-202751","journal-title":"J Clin Pathol"},{"issue":"7","key":"5456_CR101","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1089\/thy.2010.1634","volume":"20","author":"MN Stan","year":"2010","unstructured":"Stan MN, Bahn RS (2010) Risk Factors for Development or Deterioration of Graves\u2019 Ophthalmopathy. Thyroid 20(7):777\u2013783. https:\/\/doi.org\/10.1089\/thy.2010.1634","journal-title":"Thyroid"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-021-05456-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-021-05456-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-021-05456-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T02:07:44Z","timestamp":1646964464000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-021-05456-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,17]]},"references-count":101,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["5456"],"URL":"https:\/\/doi.org\/10.1007\/s00417-021-05456-x","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,17]]},"assertion":[{"value":"9 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}